Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
09 2023
Historique:
received: 28 03 2023
revised: 31 05 2023
accepted: 13 06 2023
medline: 4 9 2023
pubmed: 19 6 2023
entrez: 18 6 2023
Statut: ppublish

Résumé

To elucidate the spectrum of metastatic solid tumors to the testis and their clinicopathologic features. The databases and files of 26 pathology departments from 9 countries on 3 continents were surveyed to identify metastatic solid tumors to the testis and to characterize their clinicopathologic features in detail. We compiled a series of 157 cases of metastatic solid tumors that secondarily involved the testis. The mean patient age at diagnosis was 64 years (range, 12-93 years). Most patients (127/144; 88%) had clinical manifestation of the disease, with testicular mass/nodule (89/127; 70%) being the most common finding. The main mechanism of testicular involvement was metastasis in 154/157 (98%) cases. Bilateral testicular involvement was present in 12/157 (8%) patients. Concurrent or prior extratesticular metastases were present in 78/101 (77%) patients. The diagnosis was made mainly in orchiectomy specimens (150/157; 95%). Different types of carcinomas (138/157; 87%), most commonly adenocarcinoma (72/157; 46%), were the most common malignancies. The most common primary carcinomas included prostatic (51/149; 34%), renal (29/149; 20%), and colorectal (13/149; 9%). Intratubular growth was identified in 13/124 (11%) cases and paratesticular involvement was found in 73/152 (48%) cases. In patients with available follow-up (110/157; 70%), more than half (58/110; 53%) died of disease. In this largest series compiled to date, we found that most secondary tumors of the testis represent metastases from the genitourinary and gastrointestinal tract carcinomas and typically occur in the setting of disseminated disease.

Identifiants

pubmed: 37331529
pii: S0046-8177(23)00135-1
doi: 10.1016/j.humpath.2023.06.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-46

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Luiz M Nova-Camacho (LM)

Department of Pathology, Donostia University Hospital, San Sebastian 20014, Spain. Electronic address: luismi_15_16@hotmail.com.

Andres M Acosta (AM)

Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Faulkner Hospital, Boston, MA 02130, USA.

Kiril Trpkov (K)

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary T2V 1P9, Canada.

Ankur R Sangoi (AR)

Department of Pathology, El Camino Hospital, Mountain View, CA 94040, USA.

Allaume Pierre (A)

Department of Pathology, CHU Rennes - Hôpital Pontchaillou, Rennes 35000, France.

Angela Chou (A)

Department of Anatomical Pathology, Royal North Shore Hospital and University of Sydney, Sydney 2065, Australia.

Asli Yilmaz (A)

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary T2V 1P9, Canada.

Aurélien Morini (A)

Department of Pathology, Grand Hôpital de L'Est Francilien, Jossigny, Ile-de-France 77600, France.

Ângelo Rodrigues (Â)

Department of Pathology, Portuguese Oncology Institute of Porto, Porto 4200-072, Portugal.

Christopher D M Fletcher (CDM)

Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA.

Delia Perez-Montiel (D)

Department of Pathology, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.

Fiona Maclean (F)

Department of Pathology and Laboratory Medicine, Douglass Hanly Moir Pathology, Sonic Healthcare, Sydney 2000, Australia.

Félix Contreras (F)

Laboratorio de Patología, Clínica Universitaria Unión Médica, PUCMM, Santiago 51000, Dominican Republic.

Francisco Javier Queipo (FJ)

Department of Pathology, San Jorge University Hospital, Huesca 22004, Spain.

Gorka Muñiz Unamunzaga (G)

Department of Pathology, San Jorge University Hospital, Huesca 22004, Spain.

Hector Mesa (H)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Inés de Torres (I)

Department of Pathology, Vall D'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona 08035, Spain.

Irune Ruiz (I)

Department of Pathology, Donostia University Hospital, San Sebastian 20014, Spain.

Isabel Alvarado-Cabrero (I)

Department of Pathology Oncology, Star Medica Hospital, Oncology Hospital, IMSS, Mexico City 03810, Mexico.

João Lobo (J)

Department of Pathology, Portuguese Oncology Institute of Porto, Porto 4200-072, Portugal; Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), Porto 4200-072, Portugal; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Porto 4050-313, Portugal.

Lauren Schwartz (L)

Department of Pathology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Liang Cheng (L)

Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI 02903, USA.

Mahmut Akgul (M)

Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, USA.

María García-Martos (M)

Department of Pathology, Gregorio Marañón University Hospital, Madrid 28007, Spain.

Matthew B Palmer (MB)

Department of Pathology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Manju Aron (M)

Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Maria Rosaria Raspollini (MR)

Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence 50134, Italy.

Manuel Manrique Celada (M)

Department of Pathology, Donostia University Hospital, San Sebastian 20014, Spain.

Michael Hwang (M)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Muhammad T Idrees (MT)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Nathalie Rioux-Leclercq (N)

Department of Pathology, CHU Rennes - Hôpital Pontchaillou, Rennes 35000, France.

Nicole Zalles (N)

Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH 44106, USA.

Norge Vergara (N)

Department of Pathology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Priti Lal (P)

Department of Pathology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Sara Wobker (S)

Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Solène-Florence Kammerer-Jacquet (SF)

Department of Pathology, CHU Rennes - Hôpital Pontchaillou, Rennes 35000, France.

Susan Prendeville (S)

Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5S 1A1, Canada.

Théau Tilmant (T)

Department of Pathology, European Georges Pompidou Hospital, Université Paris-Cité, Paris 75015, France.

Thomas M Ulbright (TM)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Virginie Verkarre (V)

Department of Pathology, European Georges Pompidou Hospital, Université Paris-Cité, Paris 75015, France.

Katrina Collins (K)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Sean R Williamson (SR)

Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH 44106, USA.

Angel Panizo (A)

Department of Pathology, University Hospital of Navarra, Pamplona 31008, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH